CBD Life Sciences Inc. (OTCMKTS:CBDL) Short Interest Down 92.8% in May

CBD Life Sciences Inc. (OTCMKTS:CBDLGet Rating) saw a significant decline in short interest in May. As of May 15th, there was short interest totalling 12,200 shares, a decline of 92.8% from the April 30th total of 169,300 shares. Based on an average daily trading volume, of 125,736,100 shares, the short-interest ratio is currently 0.0 days.

Shares of OTCMKTS:CBDL traded up $0.00 during mid-day trading on Wednesday, reaching $0.00. The stock had a trading volume of 28,238,040 shares, compared to its average volume of 82,140,492. CBD Life Sciences has a 1 year low of $0.00 and a 1 year high of $0.00.

About CBD Life Sciences (Get Rating)

CBD Life Sciences Inc engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.

Featured Stories

Receive News & Ratings for CBD Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CBD Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.